We are live on
!
Find out more
TC
Tavio Capital Portfolio holdings
AUM
$75.4M
1-Year Est. Return
27.99%
This Fund
S&P 500
This Quarter
Est. Return
-3.87%
1 Year Est. Return
+27.99%
3 Year Est. Return
+81.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$189M
AUM Growth
-$57.2M
(-23%)
Cap. Flow
-$47.5M
Cap. Flow
% of AUM
-25.12%
Top 10 Holdings %
Top 10 Hldgs %
97.51%
Holding
15
New
5
Increased
4
Reduced
2
Closed
4
Top Buys
| 1 |
Humana
HUM
|
+$17.4M |
| 2 |
WMGI
Wright Medical Group Inc
WMGI
|
+$7.7M |
| 3 |
Boston Scientific
BSX
|
+$6.97M |
| 4 |
Cigna
CI
|
+$5.05M |
| 5 |
McKesson
MCK
|
+$4.95M |
Top Sells
| 1 |
Centene
CNC
|
+$34M |
| 2 |
Elevance Health
ELV
|
+$29.6M |
| 3 |
Danaher
DHR
|
+$17.8M |
| 4 |
DaVita
DVA
|
+$11.6M |
| 5 |
Zimmer Biomet
ZBH
|
+$8.35M |
Sector Composition
| 1 | Healthcare | 97.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Zimmer Biomet
ZBH
$17.6B
| $39.1M | 20.64% |
293,059
-64,618
| -18% | -$8.35M |
|
2
Labcorp
LH
$23.2B
| $32.9M | 17.4% |
228,046
+20,376
| +10% | +$2.97M |
|
|
3
McKesson
MCK
$98.5B
| $25.4M | 13.4% |
185,502
+34,917
| +23% | +$4.95M |
|
4
Molina Healthcare
MOH
$11.7B
| $24.3M | 12.87% |
221,878
-13,808
| -6% | -$1.79M |
|
5
HCA Healthcare
HCA
$82.3B
| $17.3M | 9.12% |
143,333
+24,976
| +21% | +$3.23M |
|
|
6
Humana
HUM
$48B
| $15.8M | 8.36% |
+61,885
| New | +$17.4M |
|
|
PDCO
7
DELISTED
Patterson Companies, Inc.
PDCO
| $11.6M | 6.14% |
651,397
+141,343
| +28% | +$2.64M |
|
|
8
Boston Scientific
BSX
$65.4B
| $6.69M | 3.54% |
+164,433
| New | +$6.97M |
|
|
WMGI
9
DELISTED
Wright Medical Group Inc
WMGI
| $6.68M | 3.53% |
+323,625
| New | +$7.7M |
|
|
PRAH
10
DELISTED
PRA Health Sciences, Inc.
PRAH
| $4.77M | 2.52% |
+48,063
| New | +$4.77M |
|
|
11
Cigna
CI
$74.5B
| $4.71M | 2.49% |
+31,004
| New | +$5.05M |
|
|
12
Centene
CNC
$32.8B
| – | – |
-648,822
| Closed | -$34M |
|
|
13
Danaher
DHR
$144B
| – | – |
-140,483
| Closed | -$17.8M |
|
|
14
DaVita
DVA
$15.2B
| – | – |
-206,338
| Closed | -$11.6M |
|
|
15
Elevance Health
ELV
$80.9B
| – | – |
-104,849
| Closed | -$29.6M |
|
Similar funds
PC
EGPO
AIS
MCMT
NBG
FC
SCM
MVM
Tavio Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Tavio Capital held 15 positions worth $189M, down 23% from $246M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Tavio Capital withdrew a net $47.5M in Q3 2019, closing 4 positions and reducing 2 holdings. Its most notable exit was Centene, an estimated $34M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 100% a quarter earlier.
Against the trend, Tavio Capital opened a new position in Humana worth $15.8M.
- Tavio Capital's largest Q3 2019 buy was Humana: 61,885 shares worth $15.8M.
- Tavio Capital added most to McKesson in Q3 2019, an estimated $4.95M increase.
- Tavio Capital's biggest Q3 2019 reduction was Zimmer Biomet, cutting an estimated $8.35M.
- Tavio Capital fully exited Centene in Q3 2019, selling an estimated $34M.
- Tavio Capital's ten largest holdings make up 98% of its $189M portfolio in Q3 2019.
- Tavio Capital opened 5 new positions and closed 4 in Q3 2019.
- Tavio Capital's portfolio value fell 23% quarter-over-quarter to $189M.
Based on Tavio Capital's 13F filing for Q3 2019, filed 13 Nov 2019.